FCM Permeabilization Buffer For permeabilizing fixed cells prior to IC staining with fluorochrome-conjugated antibodies.

FCM Permeabilization Buffer

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 111ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
FCM Permeabilization Buffer is rated 5.0 out of 5 by 2.
loading
5
2
4
0
3
0
2
0
1
0
Solicitud: FCM Permeabilization buffer (1X) is for permeabilizing fixed cells prior to IC staining with fluorochrome-conjugated antibodies
Información suplementaria: This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
Para Uso Exclusivo en Investigación. No está diseñado para uso en diagnosis o terapia.
* En el Certificado de Análisis específico de lote, puede encontrar información específica (como el contenido en agua).
loading

FCM Permeabilization buffer (1X) is intended solely for permeabilizing fixed cells prior to intracellular staining with fluorochrome-conjugated antibodies. FCM Permeabilization buffer does not need to be present at any other steps following permeabilization.

Uso :
Prior to use, FCM Permeabilization Buffer must be chilled to -20° C. FCM Permeabilization buffer (1X) may be stored long term at -20°C, 4°C or RT.
Estado de Materia :
Liquid
ALMACENAMIENTO :
Store at room temperature
Punto de ebullición :
64° C
Para Uso Exclusivo en Investigación. No está diseñado para uso en diagnosis o terapia.
Transporte :
UN 1230, Class 3(6.1), Packing group II

Descargar SDS (MSDS)

CERTIFICADO DE ANÁLISIS

Necesita Adobe Acrobat Reader para ver de forma fiable,
imprimir y comentar el documento de PDF

FCM Permeabilization Buffer  Menciones del Producto

Ver como otros han utilizado FCM Permeabilization Buffer. Haga click en la entrada de PubMed .

Citaciones 1 a 10 de un total de 16

PMID: # 31009502  Fathi, E.|Farahzadi, R.|Valipour, B.|Sanaat, Z.| et al. 2019. PLoS ONE. 14: e0215678.

PMID: # 31666661  Takeura, N.|Nakajima, H.|Watanabe, S.|Honjoh, K.|Takahashi, A.|Matsumine, A.| et al. 2019. Sci Rep. 9: 15656.

PMID: # 28474171  Okuma, KF.|Menuki, K.|Tsukamoto, M.|Tajima, T.|Fukuda, H.|Okada, Y.|Mori, T.|Tsuchiya, T.|Kawamoto, T.|Yoshida, Y.|Uchida, S.|Sakai, A.| et al. 2017. Calcif. Tissue Int. 101: 328-340.

PMID: # 28058860  Mehdizadeh, A. et al. 2017. Artif Cells Nanomed Biotechnol. 1-8.

PMID: # 28031237  Kim, BA.|Jee, HG.|Yi, JW.|Kim, SJ.|Chai, YJ.|Choi, JY.|Lee, KE.| et al. 2017. Cancer Genomics Proteomics. 14: 53-67.

PMID: # 27359377  Hoa, NT. et al. 2016. Expert Opin. Ther. Targets. 20: 1155-67.

PMID: # 26730203  2016. OncoTargets and therapy. 9: 49-59.

PMID: # 25511472  Wada, S. et al. 2015. Free Radic. Res. 49: 269-78.

PMID: # 25901196  Hoa, NT. et al. 2015. Am J Transl Res. 7: 271-84.

PMID: # 22778761  Romero, MM. et al. 2012. Clin. Dev. Immunol. 2012: -.

Citaciones 1 a 10 de un total de 16
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 119ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 7ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;